Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AWAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LACE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEDAG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASGRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL39L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF793 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSR4P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSD3B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHMT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ARHGEF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNQ5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPST2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on